Epicrispr Biotechnologies vs Rocket Pharmaceuticals

Epicrispr Biotechnologies vs Rocket Pharmaceuticals, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Rocket Pharmaceuticals on 57/100.

Epicrispr Biotechnologies logo
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Try Epicrispr Biotechnologies
Rocket Pharmaceuticals logo
Rocket PharmaceuticalsA biotechnology company developing genetic therapies for rare disorders.
Try Rocket Pharmaceuticals

Where each one leads

Epicrispr Biotechnologies

  • our overall score: 62/100 against 57/100

Rocket Pharmaceuticals

  • domain rating: 52/100 against 40/100
  • headcount: 100 against 51
  • funding raised: $383M against $90.0M

At a glance

MeasureEpicrispr BiotechnologiesRocket Pharmaceuticals
What it isEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).A biotechnology company developing genetic therapies for rare disorders.
CategoryBiotechnology, Therapeutics, Rare Diseases, EpigeneticsBiotechnology, Pharmaceuticals, Healthcare, Genetics
Sells toBusiness modelB2BB2B
OfferingPlatformServices
Founded20202015
HeadquartersSouth San Francisco, United StatesCranbury, USA
StatusActiveActive

Size, funding and growth

MeasureEpicrispr BiotechnologiesRocket Pharmaceuticals
Employees51100
Total funding$90.0M$383M
Latest roundSeries CAcquisition
ValuationNot published$1.1B
LinkedIn followers7,025Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEpicrispr BiotechnologiesRocket Pharmaceuticals
StartupHub scoreOur 0-100 rating62/10057/100
Traction57/10060/100
Team40/10050/100
Search visibility20/10014/100
Quality78/10068/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)D (40/100)
Domain ratingLink authority, 0-10040/10052/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEpicrispr BiotechnologiesRocket Pharmaceuticals
CDNCloudflareCloudflare
CMSWordPressWordPress
FrameworksJquery, Tailwind CSS, BootstrapJquery, Bootstrap
AnalyticsGoogle Analytics 4Google Tag Manager

Epicrispr Biotechnologies vs Rocket Pharmaceuticals: common questions

Which is better, Epicrispr Biotechnologies or Rocket Pharmaceuticals?

On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 57/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.

How do Epicrispr Biotechnologies and Rocket Pharmaceuticals compare on the numbers?

Epicrispr Biotechnologies leads on our overall score (62/100 against 57/100). Rocket Pharmaceuticals leads on domain rating (52/100 against 40/100), headcount (100 against 51), funding raised ($383M against $90.0M).

Read the full Epicrispr Biotechnologies review and pricing or the Rocket Pharmaceuticals review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.